Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages

Author:

Gulay Kevin Christian M.,Aoshima Keisuke,Maekawa Naoya,Suzuki Tamami,Konnai Satoru,Kobayashi Atsushi,Kimura Takashi

Abstract

AbstractHemangiosarcoma (HSA) is a malignant tumor derived from endothelial cells. Tumor-associated macrophages are one of the major components of tumor microenvironment and crucial for cancer development. The presence and function of macrophages in HSA have not been studied because there is no syngeneic model for HSA. In this study, we evaluated two mouse HSA cell lines and one immortalized mouse endothelial cell line for their usefulness as syngeneic models for canine HSA. Our results showed that the ISOS-1 cell line developed tumors with similar morphology to canine HSA. ISOS-1 cells highly expressed KDM2B and had similar KDM2B target expression patterns with canine HSA. Moreover, we determined that in both ISOS-1 and canine HSA tumors, macrophages were present as a major constituent of the tumor microenvironment. These macrophages were positive for CD204, an M2 macrophage marker, and express PD-L1, an immune checkpoint molecule. Canine HSA with macrophages expressing PD-L1 had a smaller number of T-cells in tumor tissues than tumors with PD-L1 negative macrophages. ISOS-1-conditioned medium could induce M2 polarization and PD-L1 expression in RAW264.7 mouse macrophage cell line and mouse peritoneal macrophages. These results show that ISOS-1 can be used as a syngenic model for canine HSA and suggest that macrophages play an important role in immune evasion in HSA. Using the syngeneic mouse model for canine HSA, we can further study the role of immune cells in the pathology of HSA.

Funder

Japan Society for the Promotion of Science

The Kuribayashi foundation

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference34 articles.

1. Spangler, W. L. & Culbertson, M. R. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985–1989). J. Am. Vet. Med. Assoc. 200, 829–834 (1992).

2. Prymak, C., McKee, L. J., Goldschmidt, M. H. & Glickman, L. T. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J. Am. Vet. Med. Assoc. 193, 706–712 (1988).

3. Johannes, C. M. et al. Hemangiosarcoma in cats: 53 cases (1992–2002). J. Am. Vet. Med. Assoc. 231, 1851–1856 (2007).

4. Southwood, L. L. et al. Disseminated hemangiosarcoma in the horse: 35 cases. J. Vet. Intern. Med. 14, 105–109 (2000).

5. Cohen, S. M. et al. Hemangiosarcoma in rodents: Mode-of-action evaluation and human relevance. Toxicol. Sci. 111, 4–18 (2009).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3